Naloxone Won't Touch Medetomidine. The Withdrawal That Follows Can Land Someone in the ICU for Weeks.

“It’s getting really mucky and messy, and things are turning over really quickly.” That is Elyse Powell, director of the North Carolina Harm Reduction Coalition, describing to NC Health News in August what her team is finding in drug samples around the Triangle. The thing turning over is medetomidine, a veterinary sedative that is not approved for humans and is now showing up inside street fentanyl.

Naloxone is still the first thing you reach for. It is no longer the only thing you need to know.

The CDC’s April 2 health advisory puts numbers on the shift: federal lab reports of medetomidine went from 247 in 2023 to 2,616 in 2024 to 8,233 in 2025, and 98% of the samples that contained it also contained fentanyl. Most reports came from the Northeast (52%) and Midwest (31%), and Arizona is not on the advisory’s list of named places. That is a map of where it started, not a promise of where it will stay.

Two things make it different from what providers already know. First, naloxone reverses the fentanyl in someone’s body, but the CDC says it does not reverse medetomidine, so a person can stay heavily sedated after the breathing has been restored. Second, the withdrawal is its own syndrome: a racing heart above 100 beats a minute, severe high blood pressure, shaking, chest pain, and vomiting that won’t stop, starting within hours and peaking 18 to 36 hours after last use. In bad cases it ends in a heart attack or brain swelling, and, per NC Health News, in ICU stays of weeks. It is a different animal from opioid withdrawal, and NC Health News reports the nausea resists standard medications.

If you work in an emergency department, a detox, an outreach van or a drop-in center, here is the move for this week. Add “any chance of medetomidine?” to your triage questions for anyone using fentanyl who arrives with a high heart rate and blood pressure they can’t explain, and hold the CDC’s guidance that someone without symptoms after 6 to 12 hours of observation is unlikely to develop severe withdrawal. The CDC says severe cases are treated with dexmedetomidine infusions, usually in an ICU, so know before the night shift which nearby hospitals can do that.

If you use, or love someone who does, here is what is still yours: keep carrying naloxone, because the fentanyl in the same sample is still the thing most likely to stop breathing, and call 911 even after it works, because the sedation may not lift. Naloxone doesn’t fix this one. Staying with the person does.

The supply will keep turning over, as Powell says. The only thing that has ever moved faster is a person who knows what to look for and is still in the room.